Rosuvastatin mitigates blood–brain barrier disruption in sepsis-associated encephalopathy by restoring occludin levels
Abstract Background Blood–brain barrier (BBB) disruption is a key pathological feature of sepsis-associated encephalopathy (SAE). Rosuvastatin, a third-generation statin, exhibits diverse pharmacological functions beyond its lipid-lowering capacity. However, its potential neuroprotective role in SAE...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMC
2025-02-01
|
| Serier: | European Journal of Medical Research |
| Fag: | |
| Online adgang: | https://doi.org/10.1186/s40001-025-02314-y |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|